GlaxoSmithKline Re-Teams With Chinese Biotech For COVID-19 Vaccine
Opening up yet another front in the war against COVID-19, the disease caused by the fast-spreading SARS-CoV-2 coronavirus, GlaxoSmithKline (NYSE:GSK) announced it is contributing to another vaccine research effort. The UK-based pharmaceutical giant wrote, in an update on its work combating the coronavirus and the disease, that it is …
News story posted on 2020-04-05T21:14:00.0000000Z
